Alexander Karl
- Microbiology top 0.5%
- Molecular Biology
- Immunology top 10%
- Dermatology top 5%
- Emergency Medical Services top 5%
- Co-authors
- Peter BoekstegersCorinna LebherzAchim PfosserGeorges von DegenfeldPhilip RaakeChristian KupattStefan ZahlerClaus Vogelmeier
- Topics
- Bladder and Urothelial Cancer Treatments (5 papers)Urinary and Genital Oncology Studies (4 papers)Mesenchymal stem cell research (2 papers)
- Cited by
- MicrobiologyImmunologyDermatology
- Partner nations
- GermanyUnited StatesNetherlands
In The Last Decade
Alexander Karl
15 papers receiving 791 citations
Hit Papers
Peers
Comparison fields: 5 of 88
- Microbiology 512
- Molecular Biology 317
- Immunology 309
- Dermatology 121
- Emergency Medical Services 89
Countries citing papers authored by Alexander Karl
This map shows the geographic impact of Alexander Karl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Karl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Karl more than expected).
Fields of papers citing papers by Alexander Karl
This network shows the impact of papers produced by Alexander Karl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Karl. The network helps show where Alexander Karl may publish in the future.
Co-authorship network of co-authors of Alexander Karl
This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Karl. A scholar is included among the top collaborators of Alexander Karl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Karl. Alexander Karl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 12 | |
| 5 | 4 | |
| 6 | 1 | |
| 7 | 3 | |
| 8 | 5 | |
| 9 | 1 | |
| 10 | Manual zur kognitiven Verhaltenstherapie von posttraumatischen Belastungsstörungen bei Verkehrsunfallopfern | 2 |
| 11 | 36 | |
| 12 | An angiogenic role for the human peptide antibiotic LL-37/hCAP-18breakdown → | 699 |
| 13 | 19 | |
| 14 | 3 | |
| 15 | 11 |
About Alexander Karl
Alexander Karl is a scholar working on Microbiology, Physical Therapy, Sports Therapy and Rehabilitation and Genetics, having authored 15 papers that have together received 801 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (5 papers), Urinary and Genital Oncology Studies (4 papers) and Mesenchymal stem cell research (2 papers). The work is most often cited by research in Microbiology (512 citations), Immunology (309 citations) and Dermatology (121 citations). Alexander Karl has collaborated with scholars based in Germany, United States and Netherlands. Frequent co-authors include Peter Boekstegers, Corinna Lebherz, Achim Pfosser, Georges von Degenfeld, Philip Raake, Christian Kupatt, Stefan Zahler, Claus Vogelmeier, Katja Issbrücker and Pieter S. Hiemstra. Their work appears in journals such as Journal of Clinical Investigation, Pain and Reproduction.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.